La. Admin. Code tit. 46 § LIII-703

Current through Register Vol. 50, No. 11, November 20, 2024

Section LIII-703 - Registration

A. All pharmacy interns shall meet the following requirements for registration.

1. All pharmacy interns shall register with the board. The failure to register may result in disciplinary action by the board.

a. The applicant shall submit to the board office a properly completed application no later than the end of the first semester of the first academic year at a board-approved college of pharmacy.

b. The board may issue an intern registration to the applicant, upon receipt of a properly completed application, appropriate fee, and any other documentation required by the board office.

c. The intern registration shall expire one year after the certification of graduation from a board-approved college of pharmacy.

i. Intern registrations issued to foreign pharmacy graduates shall expire two years after the date of issue.

d. The board shall reserve the right to recall or refuse to issue any intern registration for cause.

2. A pharmacy intern shall wear appropriate attire and be properly identified with his name and intern status while on duty at the preceptor site.

3. A pharmacy intern shall notify the board in writing within 10 days of a change of address. This notice shall include the pharmacy interns name, registration number, and old and new addresses.

4. A pharmacy intern shall notify the board in writing within 10 days of a change in location(s) of employment. This notice shall include the pharmacy interns name and registration number, the name and address of old and new employment, and the permit numbers of those pharmacies involved.

5. The pharmacy intern shall be non-impaired.

a. The pharmacy intern is subject to confidential random drug screen testing and/or evaluations.

b. A positive drug screen may be self evident as proof of improper drug use. For the purposes of this Chapter, a missed screen, a screen submitted beyond the mandated period, and/or any screen submitted indicating the sample provided is diluted, substituted, or in any way adulterated is considered to be a positive drug screen.

La. Admin. Code tit. 46, § LIII-703

Promulgated by the Department of Health and Hospitals, Board of Pharmacy, LR 29:2086 (October 2003), effective January 1, 2004, Amended by the Department of Health, Board of Pharmacy, LR 432163 (11/1/2017).

AUTHORITY NOTE: Promulgated in accordance with R.S. 37:1211.